Factors associated with hepatic steatosis in obese children and adolescents

Journal of Pediatric Gastroenterology and Nutrition

Volumn 53, Issue 2, 2011, Pages 196-201

  Ruiz Extremera, Ángeles ^a   Carazo, Ángel ^b   Salmerón, Ángela ^c   León, Josefa ^b   Casado, Jorge ^b   Goicoechea, Alejandro ^d   Fernandez, José Manuel ^a   Garofano, Maximiliano ^a   Ocete, Esther ^a   Martín, Ana Belén ^b   Pavón, Esther ^b   Salmerón, Javier ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^d JUNTA DE ANDALUCÍA   (Spain)

Author keywords

childhood obesity; hepatic steatosis; insulin resistance; oxidative stress

Indexed keywords

ADIPOCYTOKINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; C PEPTIDE; CYTOKINE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LEPTIN RECEPTOR; PRASTERONE SULFATE; RESISTIN; TRIACYLGLYCEROL;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHILD; DISEASE PREDISPOSITION; ECHOGRAPHY; ENZYME ACTIVITY; FATTY LIVER; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; OXIDATIVE STRESS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADOLESCENT DEVELOPMENT; BODY MASS INDEX; CHILD; CHILD DEVELOPMENT; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DISEASE SUSCEPTIBILITY; FATTY LIVER; HOSPITALS, UNIVERSITY; HUMANS; INSULIN RESISTANCE; LIVER; MALE; OBESITY; OXIDATIVE STRESS; PREVALENCE; RESISTIN; RISK FACTORS; SPAIN;

EID: 79961186344     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3182185ac4     Document Type: Article

References (44)

1. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004;350:2362-74. (Pubitemid 38702847)
2. Serra-Majem L, Aranceta-Bartrina J, Perez-Rodrigo C, et al. Prevalence and determinants of obesity in Spanish children and young people. Br J Nutr 2006;96:67-72.
3. Freedman DS, Dietz WH, Srinivasan SR, et al. Risk factors and adult body mass index among overweight children: the Bogalusa Heart Study. Pediatrics 2009;123:750-7.
4. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 2010;51:679-89.
5. Schwimmer JB, Deutsch R, Kahen T, et al. Prevalence of fatty liver in children and adolescents. Pediatrics 2006;118:1388-93. (Pubitemid 46393782)
6. Denzer C, Thiere D, Muche R, et al. Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance. J Clin Endocrinol Metab 2009;94: 3872-81.
7. Guzzaloni G, Grugni G, Minocci A, et al. Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test. Int J Obes Relat Metab Disord 2000;24:772-6. (Pubitemid 30339276)
8. D'Adamo E, Impicciatore M, Capanna R, et al. Liver steatosis in obese prepubertal children: a possible role of insulin resistance. Obesity (Silver Spring) 2008;16:677-83. (Pubitemid 351328019)
9. de Alwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol 2008;48:104-12.
10. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998;4:842-5.
11. Burgert TS, Taksali SE, Dziura J, et al. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab 2006;91:4287-94. (Pubitemid 44833400)
12. Tilg H, Moschen AR. Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends Endocrinol Metab 2008;19:371-9.
13. Wei Y, Rector RS, Thyfault JP, et al. Nonalcoholic fatty liver disease and mitochondrial dysfunction. World J Gastroenterol 2008;14: 193-9. (Pubitemid 351314298)
14. Marra F, Bertolani C. Adipokines in liver diseases. Hepatology 2009;50: 957-69.
15. Park BJ, Kim YJ, Kim DH, et al. Visceral adipose tissue area is an independent risk factor for hepatic steatosis. J Gastroenterol Hepatol 2008;23:900-7. (Pubitemid 351806572)
16. Hernández M, Sánchez E, Sobradillo B. Curvas y tablas de crecimiento. In: Argente J, Carrascosa A, Gracia R, eds. Tratado de Endocrinología Pediátrica y de la Adolescencia. 2nd ed. Barcelona: Doyma; 2000: 1441-99.
17. Kim SH, Lee JM, Kim JH, et al. Appropriateness of a donor liver with respect to macrosteatosis: application of artificial neural networks to US images-initial experience. Radiology 2005;234:793-803.
18. Verdon CP, Burton BA, Prior RL. Sample pre-treatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADPP when the Griess reaction is used to assay for nitrite. Anal Biochem 1995;224:502-8.
19. Jaskot RH, Charlet EG, Grose EC, et al. An automatic analysis of glutathione peroxidase, glutathione-S-transferase, and reductase activity in animal tissue. J Anal Toxicol 1983;7:86-8. (Pubitemid 13163283)
20. Hissin PJ, Russel H. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976;74: 214-26.
21. Tanner JM. Growth at Adolescence. Oxford, UK: Blackwell Scientific; 1962: 28-39.
22. Hassink SG, Sheslow DV, de Lancey E, et al. Serum leptin in children with obesity: relationship to gender and development. Pediatrics 1996; 98:201-3. (Pubitemid 26262130)
23. van Dielen FM, van't Veer C, Buurman WA, et al. Leptin and soluble leptin receptor levels in obese and weight-losing individuals. J Clin Endocrinol Metab 2002;87:1708-16. (Pubitemid 34615260)
24. Fernandes MT, Ferraro AA, de Azevedo RA, et al. Metabolic differences between male and female adolescents with non-alcoholic fatty liver disease, as detected by ultrasound. Acta Paediatr 2010;99:1218-23.
25. Quirós-Tejeira RE, Rivera CA, Ziba TT, et al. Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI >95th percentile. J Pediatr Gastroenterol Nutr 2007;44:228-36. (Pubitemid 46175078)
26. Shi H, Cave B, Inouye K, et al. Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance. Diabetes 2006;55:699-707. (Pubitemid 43343226)
27. Valle M, Martos R, Gascón F, et al. Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diabetes Metab 2005;31:55-62. (Pubitemid 40327593)
28. Pinhas-Hamiel O, Lerner-Geva L, Copperman NM, et al. Lipid and insulin levels in obese children: changes with age and puberty. Obesity (Silver Spring) 2007;15:2825-31.
29. Codoñer-Franch P, Bataller-Alberola A, Domingo-Camarasa JV, et al. Influence of dietary lipids on the erythrocyte antioxidant status of hypercholesterolaemic children. Eur J Pediatr 2009;168:321-7.
30. Marczak A, Jóźwiak Z. Damage to the cell antioxidative system in human erythrocytes incubated with idarubicin and glutaraldehyde. Toxicol In Vitro 2009;23:1188-94.
31. Narasimhan S, Gokulakrishnan K, Sampathkumar R, et al. Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes. Clin Biochem 2010;43:815-21.
32. Kapoor A, Sanyal AJ. Endoplasmic reticulum stress and the unfolded protein response. Clin Liver Dis 2009;13:581-90.
33. Mantena SK, Vaughn DP, Andringa KK, et al. High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo. Biochem J 2009;417:183-93.
34. Rector RS, Thyfault JP, Uptergrove GM, et al. Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. J Hepatol 2010;52:727-36.
35. Lavine JE. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr 2000;136:734-8. (Pubitemid 30415645)
36. Nobili V, Manco M, Devito R, et al. Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2006;24:1553-61. (Pubitemid 44915203)
37. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature 2001;409:307-12. (Pubitemid 32151228)
38. Nagaev I, Bokarewa M, Tarkowski A, et al. Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes. PLoS One 2006;1:e31.
39. Szalowska E, Elferink MG, Hoek A, et al. Resistin is more abundant in liver than adipose tissue and is not up-regulated by lipopolysaccharide. J Clin Endocrinol Metab 2009;94:3051-7.
40. Chen C, Jiang J, Lü JM, et al. Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Am J Physiol Heart Circ Physiol 2010;299:193-201.
41. Bo S, Ciccone G, Durazzo M, et al. Efficacy of antioxidant treatment in reducing resistin serum levels: a randomized study. PLoS Clin Trials 2007;2:e17.
42. Mazhar SM, Shiehmorteza M, Sirlin CB. Noninvasive assessment of hepatic steatosis. Clin Gastroenterol Hepatol 2009;7:135-40.
43. Charatcharoenwitthaya P, Lindor KD. Role of radiologic modalities in the management of non-alcoholic steatohepatitis. Clin Liver Dis 2007; 11:37-54. (Pubitemid 46829975)
44. Schwartz B, Jacobs DR Jr, Moran A, et al. Measurement of insulin sensitivity in children: comparison between the euglycemic hyperinsulinemic clamp and surrogate measures. Diabetes Care 2008; 31:783-8.